和铂医药-B(02142.HK)完成配售4502.2万股

Group 1 - The company, Heptagon Pharmaceuticals-B (02142.HK), announced the completion of a placement of 45.022 million shares at a price of HKD 11.50 per share on September 5, 2025 [1] - The placement was successfully executed with at least six subscribers [1] - The company also granted 843,000 stock options and 3.282 million shares as incentives [2]